Cellectis S.A. Gains 27.08%

Thu, May 14, 2020 at 05:30 PM
Cellectis S.A. Gains 27.08%

Cellectis S.A. (CLLS:NASDAQ) jumped higher at $17.41, representing a gain of 27.1%. The stock got featured on our News Catalysts scanner on Thu 07 May 20 at 06:53 PM in the 'INVESTOR UPDATE' category. From Wed 29 Apr 20, the stock recorded 60.00% Up Days and 54.55% Green Days

The share price of the company has been moving sideways in recent weeks.

About Cellectis S.A. (CLLS:NASDAQ)

Cellectis SA is a gene-editing company, employing its core proprietary technologies to develop products in the emerging field of immuno-oncology. Its two segment includes Therapeutics and Plants.

Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
Your price will remain at $9.99 USD after the discount period
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... or other trends? You're in the right place! Check StockTreats features.